The ACOR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACOR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ACOR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ACOR Detailed Price Forecast - CNN Money||View ACOR Detailed Summary - Google Finance|
|View ACOR Detailed Summary - Yahoo! Finance||View ACOR Stock Research & Analysis - Zacks.com|
|View ACOR Trends & Analysis - Trade-Ideas||View ACOR Major Holders - Barrons|
|View ACOR Call Transcripts - NASDAQ||View ACOR Breaking News & Analysis - Seeking Alpha|
|View ACOR Annual Report - CompanySpotlight.com||View ACOR OTC Short Report - OTCShortReport.com|
|View ACOR Fundamentals - TradeKing||View ACOR SEC Filings - Bar Chart|
|View Historical Prices for ACOR - The WSJ||View Performance/Total Return for ACOR - Morningstar|
|View the Analyst Estimates for ACOR - MarketWatch||View the Earnings History for ACOR - CNBC|
|View the ACOR Earnings - StockMarketWatch||View ACOR Buy or Sell Recommendations - MacroAxis|
|View the ACOR Bullish Patterns - American Bulls||View ACOR Short Pain Metrics - ShortPainBot.com|
|View ACOR Stock Mentions - StockTwits||View ACOR Stock Mentions - PennyStockTweets|
|View ACOR Stock Mentions - Twitter||View ACOR Investment Forum News - Investor Hub|
|View ACOR Stock Mentions - Yahoo! Message Board||View ACOR Stock Mentions - Seeking Alpha|
|View Insider Transactions for ACOR - SECform4.com||View Insider Transactions for ACOR - Insider Cow|
|View ACOR Major Holdings Summary - CNBC||View Insider Disclosure for ACOR - OTC Markets|
|View Insider Transactions for ACOR - Yahoo! Finance||View Institutional Holdings for ACOR - NASDAQ|
|View ACOR Stock Insight & Charts - FinViz.com||View ACOR Investment Charts - StockCharts.com|
|View ACOR Stock Overview & Charts - BarChart||View ACOR User Generated Charts - Trading View|
New Strong Sell Stocks for April 18th
Posted on Wednesday April 18, 2018
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
See what the IHS Markit Score report has to say about Acorda Therapeutics Inc.
Posted on Monday April 16, 2018
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding ACOR totaled $491 million.
Acorda to Present New Data For INBRIJA™ (levodopa inhalation powder) at 70th American Academy of Neurology Annual Meeting
Posted on Monday April 16, 2018
Acorda Therapeutics, Inc. will present new data for INBRIJA during four oral platform presentations at the upcoming American Academy of Neurology Annual Meeting in Los Angeles, taking place April 21–27, 2018.
How Analysts Rate Regenxbio and Peers in April 2018
Posted on Friday April 13, 2018
Regenxbio (RGNX) is a clinical-stage biotechnology company focused on developing gene therapy product candidates to address genetic defects. The company’s product candidate RGX-314 is designed for the treatment of wet age-related macular degeneration (or wet AMD), which is a leading cause of total and partial vision loss in the US, Europe, and Japan. The other promising product candidate in Regenxbio’s pipeline is RGX-501 for the treatment of homozygous familial hypercholesterolemia (or HoFH).